Literature DB >> 34059190

Position paper on the use of COVID-19 convalescent plasma: an update.

Daniele Prati1, Francesco Fiorin2, Pierluigi Berti3, Giustina De Silvestro4, Patrizia Accorsi5, Angelo Ostuni6.   

Abstract

Entities:  

Year:  2021        PMID: 34059190      PMCID: PMC8297677          DOI: 10.2450/2021.0150-21

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  18 in total

1.  Early safety indicators of COVID-19 convalescent plasma in 5,000 patients.

Authors:  Michael J Joyner; R Scott Wright; DeLisa Fairweather; Jonathon W Senefeld; Katelyn A Bruno; Stephen A Klassen; Rickey E Carter; Allan M Klompas; Chad C Wiggins; John Ra Shepherd; Robert F Rea; Emily R Whelan; Andrew J Clayburn; Matthew R Spiegel; Patrick W Johnson; Elizabeth R Lesser; Sarah E Baker; Kathryn F Larson; Juan G Ripoll; Kylie J Andersen; David O Hodge; Katie L Kunze; Matthew R Buras; Matthew Np Vogt; Vitaly Herasevich; Joshua J Dennis; Riley J Regimbal; Philippe R Bauer; Janis E Blair; Camille M van Buskirk; Jeffrey L Winters; James R Stubbs; Nigel S Paneth; Nicole C Verdun; Peter Marks; Arturo Casadevall
Journal:  J Clin Invest       Date:  2020-06-11       Impact factor: 14.808

2.  SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.

Authors:  Jinal N Bhiman; Penny L Moore; Constantinos Kurt Wibmer; Frances Ayres; Tandile Hermanus; Mashudu Madzivhandila; Prudence Kgagudi; Brent Oosthuysen; Bronwen E Lambson; Tulio de Oliveira; Marion Vermeulen; Karin van der Berg; Theresa Rossouw; Michael Boswell; Veronica Ueckermann; Susan Meiring; Anne von Gottberg; Cheryl Cohen; Lynn Morris
Journal:  Nat Med       Date:  2021-03-02       Impact factor: 53.440

3.  Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.

Authors:  Patrizia Accorsi; Pierluigi Berti; Vincenzo de Angelis; Giustina De Silvestro; Luca Mascaretti; Angelo Ostuni
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

4.  Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.

Authors:  Perrine Janiaud; Cathrine Axfors; Andreas M Schmitt; Viktoria Gloy; Fahim Ebrahimi; Matthias Hepprich; Emily R Smith; Noah A Haber; Nina Khanna; David Moher; Steven N Goodman; John P A Ioannidis; Lars G Hemkens
Journal:  JAMA       Date:  2021-03-23       Impact factor: 56.272

5.  Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.

Authors:  Judith A Aberg; Nicole M Bouvier; Sean T H Liu; Hung-Mo Lin; Ian Baine; Ania Wajnberg; Jeffrey P Gumprecht; Farah Rahman; Denise Rodriguez; Pranai Tandon; Adel Bassily-Marcus; Jeffrey Bander; Charles Sanky; Amy Dupper; Allen Zheng; Freddy T Nguyen; Fatima Amanat; Daniel Stadlbauer; Deena R Altman; Benjamin K Chen; Florian Krammer; Damodara Rao Mendu; Adolfo Firpo-Betancourt; Matthew A Levin; Emilia Bagiella; Arturo Casadevall; Carlos Cordon-Cardo; Jeffrey S Jhang; Suzanne A Arinsburg; David L Reich
Journal:  Nat Med       Date:  2020-09-15       Impact factor: 53.440

6.  Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.

Authors: 
Journal:  Lancet       Date:  2021-05-14       Impact factor: 79.321

7.  Effects of the COVID-19 pandemic on supply and use of blood for transfusion.

Authors:  Simon J Stanworth; Helen V New; Torunn O Apelseth; Susan Brunskill; Rebecca Cardigan; Carolyn Doree; Marc Germain; Mindy Goldman; Edwin Massey; Daniele Prati; Nadine Shehata; Cynthia So-Osman; Jecko Thachil
Journal:  Lancet Haematol       Date:  2020-07-03       Impact factor: 18.959

8.  (A Little) Clarity on Convalescent Plasma for Covid-19.

Authors:  Louis M Katz
Journal:  N Engl J Med       Date:  2021-01-13       Impact factor: 91.245

9.  A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.

Authors:  Ventura A Simonovich; Leandro D Burgos Pratx; Paula Scibona; María V Beruto; Marcelo G Vallone; Carolina Vázquez; Nadia Savoy; Diego H Giunta; Lucía G Pérez; Marisa Del L Sánchez; Andrea Vanesa Gamarnik; Diego S Ojeda; Diego M Santoro; Pablo J Camino; Sebastian Antelo; Karina Rainero; Gabriela P Vidiella; Erica A Miyazaki; Wanda Cornistein; Omar A Trabadelo; Fernando M Ross; Mariano Spotti; Gabriel Funtowicz; Walter E Scordo; Marcelo H Losso; Inés Ferniot; Pablo E Pardo; Eulalia Rodriguez; Pablo Rucci; Julieta Pasquali; Nora A Fuentes; Mariano Esperatti; Gerardo A Speroni; Esteban C Nannini; Alejandra Matteaccio; Hernán G Michelangelo; Dean Follmann; H Clifford Lane; Waldo H Belloso
Journal:  N Engl J Med       Date:  2020-11-24       Impact factor: 91.245

10.  Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.

Authors:  Michael J Joyner; Katelyn A Bruno; Stephen A Klassen; Katie L Kunze; Patrick W Johnson; Elizabeth R Lesser; Chad C Wiggins; Jonathon W Senefeld; Allan M Klompas; David O Hodge; John R A Shepherd; Robert F Rea; Emily R Whelan; Andrew J Clayburn; Matthew R Spiegel; Sarah E Baker; Kathryn F Larson; Juan G Ripoll; Kylie J Andersen; Matthew R Buras; Matthew N P Vogt; Vitaly Herasevich; Joshua J Dennis; Riley J Regimbal; Philippe R Bauer; Janis E Blair; Camille M van Buskirk; Jeffrey L Winters; James R Stubbs; Noud van Helmond; Brian P Butterfield; Matthew A Sexton; Juan C Diaz Soto; Nigel S Paneth; Nicole C Verdun; Peter Marks; Arturo Casadevall; DeLisa Fairweather; Rickey E Carter; R Scott Wright
Journal:  Mayo Clin Proc       Date:  2020-07-19       Impact factor: 7.616

View more
  4 in total

1.  Convalescent plasma for COVID-19. TSUNAMI is not the final word.

Authors:  Massimo Franchini; Daniele Focosi; Arturo Casadevall; Michael J Joyner; Cesare Perotti
Journal:  Eur J Intern Med       Date:  2022-01-07       Impact factor: 4.487

2.  Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donors.

Authors:  Luca Valenti; Serena Pelusi; Alessandro Cherubini; Cristiana Bianco; Luisa Ronzoni; Sara Uceda Renteria; Elena Coluccio; Alessandra Berzuini; Angela Lombardi; Leonardo Terranova; Francesco Malvestiti; Giuseppe Lamorte; Elisa Erba; Massimo Oggioni; Ferruccio Ceriotti; Daniele Prati
Journal:  Transfusion       Date:  2021-10-14       Impact factor: 3.157

3.  Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients.

Authors:  Massimo Franchini; Daniele Focosi; Elena Percivalle; Massimiliano Beccaria; Martina Garuti; Omar Arar; Antonietta Pecoriello; Fabio Spreafico; Graziana Greco; Stefano Bertacco; Marco Ghirardini; Tiziana Santini; Michele Schiavulli; Muzzica Stefania; Thaililja Gagliardo; Josè Camilla Sammartino; Alessandro Ferrari; Matteo Zani; Alessia Ballotari; Claudia Glingani; Fausto Baldanti
Journal:  Viruses       Date:  2022-06-30       Impact factor: 5.818

4.  Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?

Authors:  Sanda Ravlić; Ana Hećimović; Tihana Kurtović; Jelena Ivančić Jelečki; Dubravko Forčić; Anamarija Slović; Ivan Christian Kurolt; Željka Mačak Šafranko; Tatjana Mušlin; Dina Rnjak; Ozren Jakšić; Ena Sorić; Gorana Džepina; Oktavija Đaković Rode; Kristina Kujavec Šljivac; Tomislav Vuk; Irena Jukić; Alemka Markotić; Beata Halassy
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.